Market Overview

ADMA Biologics (NASDAQ: ADMA)

2.25 -0.14 (-5.67%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.26
10.2M



Q4 2020
After-Hours
EPS:
REV:
-0.18
12.037M



Q3 2020
After-Hours
EPS:
REV:
-0.19
7.223M



Q2 2020
After-Hours
EPS:
REV:
-0.25
6.561M
-0.16
10.57M
-0.23
7.788M
-43.75%
-26.32%
Q1 2020
After-Hours
EPS:
REV:
-0.28
3.529M
-0.12
10.88M
-0.26
10.2M
-116.67%
-6.25%
Q4 2019
After-Hours
EPS:
REV:
-0.39
4.056M
-0.18
10.23M
-0.18
12.037M
0%
17.66%
Q3 2019
After-Hours
EPS:
REV:
-0.33
4.23M

-0.19
7.223M

Q2 2019
Pre-Market
EPS:
REV:
-0.35
4.657M
-0.29
3.34M
-0.25
6.561M
13.79%
96.44%
Q1 2019
After-Hours
EPS:
REV:
-0.39
4.042M
-0.32
3.22M
-0.28
3.529M
12.5%
9.6%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!